IP Library › Granted Patent US 12,271,585
Granted Patent B2
US 12,271,585 · App. 18/194,593 · Granted Apr 8, 2025

Graphical user interface for a flow therapy apparatus

Inventors: Jae Chul Han (Auckland, NZ); Hamish Chan (Auckland, NZ); Michael Jesse Robertson (Auckland, NZ); Kevin Peter O'Donnell (Auckland, NZ); Christopher Malcolm Crone (Auckland, NZ); Robert Stuart Kirton (Auckland, NZ); James Alexander Michael Revie (Auckland, NZ); Jose Ricardo Joven Catapang (Auckland, NZ); Jonathan Jaeheuk Lee (Auckland, NZ); Hayden Ross Purdy (Auckland, NZ); Anton Kim Gulley (Auckland, NZ); Christopher Harding Campbell (Auckland, NZ)
Assignee: Fisher & Paykel Healthcare Limited
G06F3/04847A61B5/14551A61B5/7425A61B5/746A61M16/06G06F3/04817A61M2205/3334A61M2205/505A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,271,585
App. No.
18/194,593
Filed
Mar 31, 2023
Granted
Apr 8, 2025
Kind
B2
Art Unit
2148
USPC
715/771
Abstract

The present disclosure provides to graphical user interfaces for controlling a flow therapy apparatus. The graphical user interface can provide a display of flow therapy treatment information and indicators of a patient's health. The graphical user interface can be configured to display the information associated with the patient on one or more user interface screens.

Claims (29)

1. A breathing assistance apparatus comprising:

a housing;

a display; and

one or more processors configured with computer readable instructions to:

generate a graphical user interface on the display, the graphical user interface comprising:

a parameter display section comprising a first plurality of parameter display elements, each parameter display element associated with a parameter of the breathing assistance apparatus;

receive a request to configure the breathing assistance apparatus in an automatic mode;

generate a configuration graphical user interface displaying at least one patient type for configuring the automatic mode, wherein the at least one patient type is associated with a first parameter;

receive an indication of a selection of a first patient type;

determine control limits for the first parameter of the breathing assistance apparatus based on the first patient type; and

operate the breathing assistance apparatus in the automatic mode using the control limits for the first parameter of the breathing assistance apparatus, wherein at least in the automatic mode the breathing assistance apparatus delivers high-flow therapy via a non-sealed patient interface comprising at least one nasal prong.

2. The breathing apparatus of claim 1 , wherein the first parameter is SpO2, and the control limits are for the SpO2.

3. The breathing apparatus of claim 2 , wherein the at least one patient type identifies a plurality of types of patients.

4. The breathing apparatus of claim 3 , wherein the plurality of patient types include at least one of patient condition, patient weight, patient height, patient age, or patient gender.

5. The breathing apparatus of claim 4 , wherein the first patient type is a normal patient condition.

6. The breathing apparatus of claim 5 , wherein the SpO2 control limits for a normal type of patient are 92% SpO2 and 96% SpO2.

7. The breathing apparatus of claim 6 , wherein a target SpO2 value is identified within the SpO2 control limits.

8. The breathing apparatus of claim 4 , wherein the first patient type is a hypercapnic patient condition.

9. The breathing apparatus of claim 8 , wherein the SpO2 control limits for a hypercapnic type of patient are 88% SpO2 and 92% SpO2.

10. The breathing apparatus of claim 9 , wherein a target SpO2 value is identified within the SpO2 control limits.

11. The breathing apparatus of claim 3 , wherein control limits associated with the first parameter are configured to be displayed next to each type of patient.

12. The breathing apparatus of claim 2 , wherein the at least one patient type comprise a plurality of patient types and each patient type is associated with an alphanumeric identifier.

13. The breathing apparatus of claim 2 , wherein each alphanumeric identifier is associated with a set of defined control limits.

14. The breathing apparatus of claim 2 , wherein the one or more processors are further configured to determine control limits associated with a second parameter.

15. The breathing apparatus of claim 14 , wherein second parameter is FiO2.

16. The breathing apparatus of claim 15 , wherein the FiO2 control limits are adjustable by a user.

17. The breathing apparatus of claim 15 , wherein the FiO2 control limits comprise an upper control limit and a lower control limit, wherein the upper control limit and the lower control limit are configured to be simultaneously adjusted when the user adjusts an input associated with the FiO2 control limits.

18. The breathing apparatus of claim 15 , wherein the FiO2 control limits are a percentage range from a defined starting value.

19. The breathing apparatus of claim 14 , wherein the one or more processors are further configured to provide a linking indicator visually linking parameter display elements for the first parameter with parameter display elements for the second parameter during the automatic mode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2024
From: HAN, JAE CHUL; CHAN, HAMISH; ROBERTSON, MICHAEL JESSE; O'DONNELL, KEVIN PETER; CRONE, CHRISTOPHER MALCOLM; KIRTON, ROBERT STUART; REVIE, JAMES ALEXANDER MICHAEL; CATAPANG, JOSE RICARDO JOVEN; LEE, JONATHAN JAEHEUK; PURDY, HAYDEN ROSS; GULLEY, ANTON KIM; CAMPBELL, CHRISTOPHER HARDING
To: FISHER & PAYKEL HEALTHCARE LIMITED
Reel/Frame 069557/0819 →
Continuity (3)
Continuation 16768606
Provisional Application 62596726 · Dec 8, 2017
Related Publication 20230350557A1 · Nov 2, 2023
References Cited (124)
US 5881723A · Wallace et al. · 1999 [cited by applicant]
US 6369838B1 · Wallace et al. · 2002 [cited by applicant]
US 6543449B1 · Woodring et al. · 2003 [cited by applicant]
US D590414S · Bhat et al. · 2009 [cited by applicant]
US 7623888B1 · Wolter · 2009 [cited by applicant]
US 7736132B2 · Bliss et al. · 2010 [cited by applicant]
US D630641S · Bamford · 2011 [cited by applicant]
US 8006691B2 · Kenyon et al. · 2011 [cited by applicant]
US D645469S · Gardner et al. · 2011 [cited by applicant]
US 8020551B2 · Virr et al. · 2011 [cited by applicant]
US 8028693B2 · Trevor-Wilson et al. · 2011 [cited by applicant]
US 8042535B2 · Kenyon et al. · 2011 [cited by applicant]
US D667837S · Magee et al. · 2012 [cited by applicant]
US D667838S · Magee et al. · 2012 [cited by applicant]
US 8576191B2 · Knott et al. · 2013 [cited by applicant]
US D701233S · Heong et al. · 2014 [cited by applicant]
US D705798S · Lim et al. · 2014 [cited by applicant]
US D706286S · Pitt · 2014 [cited by applicant]
US D720767S · Miller et al. · 2015 [cited by applicant]
US 8944057B2 · Hill et al. · 2015 [cited by applicant]
US 9031793B2 · Lynn · 2015 [cited by examiner]
US 9038631B2 · Bath et al. · 2015 [cited by applicant]
US 9038632B2 · Crumblin et al. · 2015 [cited by applicant]
US 9072848B2 · Bertinetti et al. · 2015 [cited by applicant]
US 9072860B2 · Lithgow et al. · 2015 [cited by applicant]
US 9089659B2 · Wallace et al. · 2015 [cited by applicant]
US D745023S · Kwon · 2015 [cited by applicant]
US 9227035B2 · Crumblin et al. · 2016 [cited by applicant]
US 9229630B2 · Altas et al. · 2016 [cited by applicant]
US D757040S · Zankowski et al. · 2016 [cited by applicant]
US D760275S · Zhang · 2016 [cited by applicant]
US 9358359B2 · Lithgow et al. · 2016 [cited by applicant]
US D764506S · Rathke et al. · 2016 [cited by applicant]
US 9539409B2 · Crumblin et al. · 2017 [cited by applicant]
US D781897S · Umezawa et al. · 2017 [cited by applicant]
US 9607495B2 · Tivig et al. · 2017 [cited by applicant]
US 9610420B2 · Lithgow et al. · 2017 [cited by applicant]
US D787531S · Wada · 2017 [cited by applicant]
US D788128S · Wada · 2017 [cited by applicant]
US D788143S · Wada · 2017 [cited by applicant]
US 9737675B2 · Frame et al. · 2017 [cited by applicant]
US RE46543E · Trevor-Wilson et al. · 2017 [cited by applicant]
US D806735S · Olsen et al. · 2018 [cited by applicant]
US D811425S · Olsen et al. · 2018 [cited by applicant]
US D824410S · Grubbs et al. · 2018 [cited by applicant]
US D824939S · Sagrillo et al. · 2018 [cited by applicant]
US D825590S · Sagrillo et al. · 2018 [cited by applicant]
US 10046128B2 · Hill et al. · 2018 [cited by applicant]
US D831048S · Sagrillo et al. · 2018 [cited by applicant]
US 10105506B2 · Bassin et al. · 2018 [cited by applicant]
US 10149952B2 · Bertinetti et al. · 2018 [cited by applicant]
US D837230S · Johnston et al. · 2019 [cited by applicant]
US 10201676B2 · Lithgow et al. · 2019 [cited by applicant]
US 10293125B2 · Jeha et al. · 2019 [cited by applicant]
US 10342950B2 · Bath et al. · 2019 [cited by applicant]
US D876451S · Rawohl et al. · 2020 [cited by applicant]
US D876452S · Rawohl et al. · 2020 [cited by applicant]
US D876456S · Broughton et al. · 2020 [cited by applicant]
US D885414S · Bilancio et al. · 2020 [cited by applicant]
US D896834S · Kawaichi et al. · 2020 [cited by applicant]
US 10758692B2 · Frame et al. · 2020 [cited by applicant]
US D912078S · Pellow et al. · 2021 [cited by applicant]
US D914039S · Zimmerman et al. · 2021 [cited by applicant]
US D930035S · Evans et al. · 2021 [cited by applicant]
US D942494S · Broughton et al. · 2022 [cited by applicant]
US D946025S · Vogler-Ivashchanka et al. · 2022 [cited by applicant]
US D946617S · Ahmed · 2022 [cited by applicant]
US D949904S · Hsu et al. · 2022 [cited by applicant]
US D950584S · Huang et al. · 2022 [cited by applicant]
US D954718S · Evans et al. · 2022 [cited by applicant]
US D955414S · Tompkins et al. · 2022 [cited by applicant]
US D955415S · Bennett et al. · 2022 [cited by applicant]
US 11373000B1 · Babani et al. · 2022 [cited by applicant]
US 11497879B2 · Bath et al. · 2022 [cited by applicant]
US D978157S · Han et al. · 2023 [cited by applicant]
US 20070265877A1 · Rice et al. · 2007 [cited by applicant]
US 20080099017A1 · Bordewick et al. · 2008 [cited by applicant]
US 20080183057A1 · Taube · 2008 [cited by applicant]
US 20080228464A1 · Al-Onaizan et al. · 2008 [cited by applicant]
US 20090055735A1 · Zaleski et al. · 2009 [cited by applicant]
US 20090149927A1 · Kneuer et al. · 2009 [cited by applicant]
US 20100030797A1 · Johnson et al. · 2010 [cited by applicant]
US 20100224192A1 · Dixon · 2010 [cited by examiner]
US 20100298718A1 · Gilham et al. · 2010 [cited by applicant]
US 20110067697A1 · Lellouche · 2011 [cited by examiner]
US 20120030611A1 · Skidmore · 2012 [cited by examiner]
US 20130006129A1 · Muir · 2013 [cited by examiner]
US 20130283197A1 · Skidmore · 2013 [cited by applicant]
US 20140190485A1 · Milne et al. · 2014 [cited by applicant]
US 20150094865A1 · Choi et al. · 2015 [cited by applicant]
US 20150097701A1 · Al-Ali et al. · 2015 [cited by applicant]
US 20150121315A1 · Glenn · 2015 [cited by examiner]
US 20160199612A1 · Foote et al. · 2016 [cited by applicant]
US 20160256642A1 · Soysa · 2016 [cited by examiner]
US 20160310691A1 · Bath et al. · 2016 [cited by applicant]
US 20170087327A1 · Crumblin et al. · 2017 [cited by applicant]
US 20170136198A1 · Delangre et al. · 2017 [cited by applicant]
US 20170161461A1 · Delangre et al. · 2017 [cited by applicant]
US 20170182270A1 · Kenyon et al. · 2017 [cited by applicant]
US 20170182278A1 · Allen · 2017 [cited by applicant]
US 20170239432A1 · Delangre et al. · 2017 [cited by applicant]
US 20180036543A1 · Delisle · 2018 [cited by examiner]
US 20180099109A1 · Kinsky · 2018 [cited by examiner]
US 20180232528A1 · Williamson et al. · 2018 [cited by applicant]
US 20180333550A1 · Hill et al. · 2018 [cited by applicant]
US 20180339122A1 · Lunz · 2018 [cited by examiner]
US 20180369522A1 · Bassin et al. · 2018 [cited by applicant]
US 20190125999A1 · Häussermann · 2019 [cited by examiner]
US 20190134325A1 · Bertinetti et al. · 2019 [cited by applicant]
US 20200054520A1 · Johnson · 2020 [cited by examiner]
US 20200054846A1 · Eriksson · 2020 [cited by examiner]
US 20200188615A1 · Troili · 2020 [cited by examiner]
US 20210077758A1 · Frame et al. · 2021 [cited by applicant]
US 20210181932A1 · Han et al. · 2021 [cited by applicant]
US 20230350557A1 · Han · 2023 [cited by examiner]
JP 2004524879A · 2004 [cited by applicant]
WO WO01032069 · 2001 [cited by applicant]
WO WO2013189538A1 · 2013 [cited by applicant]
WO WO14205513 · 2014 [cited by applicant]
WO WO17079798 · 2017 [cited by applicant]
WO WO2018156804A1 · 2018 [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/NZ2018/050174, mailed on May 1, 2019, in 19 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 18885477.2, dated Jul. 2, 2021, in 8 pages. [cited by applicant]
“Modes of Mechanical Ventilation” [retrieved from the internet on Apr. 12, 2019]. [cited by applicant]